RNA vaccines have been a long time coming, but were only approved after covid-19 emerged, marking the beginning of a new way of preventing – and treating – various conditions ...

Much has been made of COVID’s consequences for overall health, productivity and the economy. But recent research suggests a compelling new basis for vaccine ... New England Journal of Medicine ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

Older people with RSV are at higher risk of severe illness compared to those with influenza or COVID ... detailed in the New ...

When it comes to seasonal viruses, you’re probably concerned about the flu and COVID ... New England Journal of Medicine, researchers gave nearly 25,000 adults ages 60 and older either the RSV ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

In a recent study published in the New England Journal of Medicine ... based on which vaccine was taken. This large-sample community-based study suggests that COVID-19 may be associated with ...

Four years have passed since the global outbreak of the COVID-19 pandemic, and researchers are still conducting intensive studies ... According to the "New England Journal of Medicine," this ...